In brief
- Nasdaq-listed healthcare company Semler Scientific has bought more Bitcoin and now holds 3,303 BTC.
- Chairman Eric Semler said Thursday that shareholders skeptical of its strategy are welcome to sell.
A Nasdaq-listed healthcare company has said it won’t sell its Bitcoin—even if shareholders offload their stock.
Semler Scientific’s Chairman Eric Semler made the comments one day before the company announced another Bitcoin buy on Friday morning.
Medical device manufacturer Semler Scientific said Friday that it had bought another 111 BTC for $10 million. The company now owns 3,303 BTC, worth nearly $314 million at today’s price.
“You can sell or stop if you don’t like what we’ve done with Bitcoin,” Semler said during an interview Thursday at Bitwise’s Bitcoin Standard Corporation Investor Day event in New York.
He added: “We’re a public company. You have that right to sell or stop. If we lose money by Bitcoin, it’s not gonna force us to sell.”
Santa Clara, California-based Semler Scientific—which trades under the ticker SMLR—first started buying Bitcoin last year with a $40 million transaction to acquire 581 BTC. It has continued to scoop up the asset, copying the model of software company Strategy (formerly MicroStrategy), the largest corporate holder of Bitcoin.
Strategy began buying Bitcoin in 2020 as a way to get better returns for shareholders in the face of rising inflation brought on by the COVID-19 pandemic. The company has aggressively bought Bitcoin since, and now works to securitize the asset: Investors can buy shares of the firm to get exposure to Bitcoin’s price.
The company now owns 538,000 BTC—or $51 billion worth of the cryptocurrency.
Other companies on the Nasdaq are following suit, such as Cosmos Health and auto firm Worksport.
Semler Scientific stock is currently up nearly 3% on Friday, trading for $35.40 a share. Bitcoin is up nearly 2% on the day, cracking the $95,000 mark for the first time in two months.
Additional reporting by Liz Napolitano
Edited by Andrew Hayward
Daily Debrief Newsletter
Start every day with the top news stories right now, plus original features, a podcast, videos and more.
